BIOGEN INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 201.2 USD | -0.62% |
|
+6.27% | -21.76% |
| Apr. 25 | Biogen Inc. Receives Positive CHMP Opinion for TOFIDence (tocilizumab), a Biosimilar Referencing ROACTEMRA | CI |
| Apr. 25 | Goldman Sachs Adjusts Biogen Price Target to $340 From $393 | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-22 | 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|---|
| Last | 194.11 $ | 193.18 $ | 201.99 $ | 202.46 $ | 202.5 $ |
| Volume | 1 119 536 | 1 461 694 | 3 265 676 | 1 590 300 | 1 590 300 |
| Change | -0.14% | -0.48% | +4.56% | +0.23% | -0.62% |
| Opening | 196.19 | 193.34 | 198.97 | 201.21 | 201.2 |
| High | 196.78 | 195.86 | 205.75 | 205.36 | 205.4 |
| Low | 193.23 | 192.75 | 198.97 | 198.11 | 198.1 |
Performance
| 1 day | -0.62% | ||
| 1 week | +6.27% | ||
| Current month | -6.11% | ||
| 1 month | -6.57% | ||
| 3 months | -17.77% | ||
| 6 months | -17.94% | ||
| Current year | -21.76% | ||
| 1 year | -28.31% | ||
| 3 years | -22.91% | ||
| 5 years | -11.93% | ||
| 10 years | -29.16% |
Volumes
marketsDaily volume
1 590 300
Estimated daily volume
1 590 300
Avg. Volume 20 sessions
1 260 038
Daily volume ratio
1.26
Avg. Volume 20 sessions USD
253 519 645.60
Record volume 1
118 284 800
Record volume 2
52 544 850
Record volume 3
41 080 670
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
29 477 547 361
Net sales (USD)
9 836 000 000
Number of employees
7 570
Sales / Employee (USD)
1 299 339
Free-Float
85.22 %
Free-Float capitalization (USD)
29 227 205 166
Average Daily Capital Traded
0.86%
Highs and lows
1 week
192.75
205.75
1 month
189.44217.57
Current year
189.44268.30
1 year
189.44319.76
3 years
187.16468.55
5 years
187.16468.55
10 years
187.16480.18
Indicators
Moving average 5 days
197.22
Moving average 20 days
202.16
Moving average 50 days
213.44
Moving average 100 days
230.69
Price spread / (MMA5)
-1.98%
Price spread / (MMA20)
+0.48%
Price spread / (MMA50)
+6.08%
Price spread / (MMA100)
+14.66%
STIM
RSI 9 days
53.27
RSI 14 days
46.03
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.62% | +6.27% | -21.76% | -28.31% | 29.48B | ||
| -1.85% | +1.41% | -4.66% | -10.60% | 87.53B | ||
| -1.27% | -1.27% | +2.63% | -0.76% | 40.42B | ||
| -0.12% | +1.98% | +56.65% | +44.97% | 25.43B | ||
| +0.83% | -3.10% | -18.49% | -30.41% | 11.49B | ||
| +0.38% | -17.23% | -44.02% | -36.10% | 11.3B | ||
| -1.92% | -5.77% | -15.61% | -15.90% | 11.1B | ||
| -0.85% | +6.44% | +4.04% | +6.03% | 8.75B | ||
| +1.56% | +17.92% | -8.42% | +2.49% | 7.99B | ||
| +0.62% | +0.18% | +0.71% | +18.65% | 7.67B | ||
| -2.58% | -1.42% | +76.35% | +291.22% | 6.7B | ||
| +2.69% | +3.86% | -9.25% | +17.67% | 6.66B | ||
| +0.81% | +2.20% | -6.98% | +7.63% | 6.55B | ||
| +3.60% | +0.88% | -19.93% | -45.18% | 5.78B | ||
| +3.02% | +0.05% | -45.97% | -7.33% | 5.23B | ||
| -0.26% | +0.58% | -13.96% | -18.11% | 4.81B | ||
| Average | +0.27% | +0.92% | -4.29% | +12.25% | ||
| Weighted average by Cap. | -0.69% | +1.56% | -1.55% | +1.32% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -21.76% | ||
| 2023 | -6.55% | ||
| 2022 | +15.42% | ||
| 2021 | -2.02% | ||
| 2020 | -17.48% | ||
| 2019 | -1.39% | ||
| 2018 | -5.54% | ||
| 2017 | +12.34% | ||
| 2016 | -7.43% | ||
| 2015 | -9.75% | ||
| 2014 | +21.42% | ||
| 2013 | +91.00% | ||
| 2012 | +33.00% | ||
| 2011 | +64.13% | ||
| 2010 | +25.33% | ||
| 2009 | +12.32% | ||
| 2008 | -16.32% | ||
| 2007 | +15.71% | ||
| 2006 | +8.64% | ||
| 2005 | -32.02% | ||
| 2004 | +81.50% | ||
| 2003 | +10.64% | ||
| 2002 | -51.88% | ||
| 2001 | +9.09% | ||
| 2000 | +92.94% | ||
| 1999 | +318.09% | ||
| 1998 | +36.73% | ||
| 1997 | +44.74% | ||
| 1996 | +21.79% | ||
| 1995 | +817.64% | ||
| 1994 | -63.04% | ||
| 1993 | -34.29% | ||
| 1992 | -32.69% | ||
| 1991 | -29.73% |
- Stock Market
- Equities
- BIIB Stock
- Quotes Biogen Inc.
